These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3293393)

  • 21. Influence of calcium channel antagonist therapy on the ischemic response to acute coronary occlusion in humans.
    Kern MJ
    Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III77-85. PubMed ID: 2691144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic and angiographic comparison of intravenous nitroglycerin and nicardipine mainly in subjects without coronary artery disease.
    Lambert CR; Grady T; Hashimi W; Blakely M; Panayioutou H
    Am J Cardiol; 1993 Feb; 71(5):420-3. PubMed ID: 8430630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of intravenous and intracoronary nicardipine.
    Lambert CR; Pepine CJ
    Am J Cardiol; 1989 Oct; 64(15):8H-15H. PubMed ID: 2801574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coronary vasomotion during dynamic exercise: influence of intravenous and intracoronary nicardipine.
    Kaufmann P; Vassalli G; Utzinger U; Hess OM
    J Am Coll Cardiol; 1995 Sep; 26(3):624-31. PubMed ID: 7642851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of nicardipine on myocardial function in vitro and in vivo.
    Lambert CR; Buss DD; Pepine CJ
    Circulation; 1990 Feb; 81(2 Suppl):III139-47. PubMed ID: 2297878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intracellular Ca++ antagonist, HA1004: pharmacological properties different from those of nicardipine.
    Asano T; Hidaka H
    J Pharmacol Exp Ther; 1985 May; 233(2):454-8. PubMed ID: 3999029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of intracoronary nicardipine, diltiazem and verapamil on coronary blood flow.
    Fugit MD; Rubal BJ; Donovan DJ
    J Invasive Cardiol; 2000 Feb; 12(2):80-5. PubMed ID: 10731269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic and hemodynamic effects of nicardipine during pacing-induced angina pectoris.
    Thomassen A; Bagger JP; Nielsen TT; Henningsen P
    Am J Cardiol; 1987 Feb; 59(4):219-24. PubMed ID: 3812268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine.
    Singh BN; Josephson MA
    Am Heart J; 1990 Feb; 119(2 Pt 2):427-34. PubMed ID: 1967896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomised comparison of the effects of nicardipine and esmolol on coronary artery wall stress: implications for the risk of plaque rupture.
    Williams MJ; Low CJ; Wilkins GT; Stewart RA
    Heart; 2000 Oct; 84(4):377-82. PubMed ID: 10995404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nicardipine augments local myocardial perfusion after coronary artery reperfusion in dogs.
    Jang YH; Kim JM
    J Korean Med Sci; 2003 Feb; 18(1):23-6. PubMed ID: 12589082
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of nicardipine for angina pectoris.
    Pepine CJ; Lambert CR
    Am J Cardiol; 1987 Jun; 59(17):13J-19J. PubMed ID: 3300237
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of two dihydropyridine calcium antagonists on coronary collateral blood flow in acute myocardial ischemia.
    Jolly SR; Hardman HF; Gross GJ
    J Pharmacol Exp Ther; 1981 Apr; 217(1):20-5. PubMed ID: 7205654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog.
    Drieu la Rochelle CD; Grosset A; O'Connor SE
    Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nicardipine, a new calcium channel blocker: role for vascular selectivity.
    Pepine C
    Clin Cardiol; 1989 May; 12(5):240-6. PubMed ID: 2656020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological profile of nicardipine hydrochloride in anesthetized dogs with acute heart failure. Part 2: Effect on myocardial metabolism.
    Saitoh C; Momose K; Tanaka H; Sato S; Taguchi K; Saitoh M; Maehara J; Asano M; Usuda S
    Arzneimittelforschung; 1998 Feb; 48(2):133-7. PubMed ID: 9541722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.
    Rousseau MF; Vincent MF; Cheron P; van den Berghe G; Charlier AA; Pouleur H
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):147S-157S. PubMed ID: 2862900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects of nicardipine on hemodynamics, regional myocardial function and myocardial metabolism in the dog with coronary artery occlusion].
    Nomura H; Ogawa S; Yasuma F; Narita G; Miyaguchi K; Hama Y; Sotobata I
    Kokyu To Junkan; 1987 Oct; 35(10):1079-85. PubMed ID: 3423440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.